You're right to ask this question. After years of data breaches making headlines, apps harvesting personal information for advertising, and AI tools with murky privacy policies, being cautious about where your health data goes is smart. It's exactly what you should be doing.

So here's the straightforward answer: yes, your health data is safe with Claimable. But you shouldn't just take our word for it – that’s why we’ve brought in independent 3rd parties to evaluate and certify every piece of our operations. Here's what those certifications mean, what protections are actually in place, and how to think about the services you choose to trust with your information.

What counts as protected health information,and where it lives today

Any time you interact with the healthcare system, you generate what's legally known as protected health information, or PHI. That includes your diagnoses, prescriptions, lab results, treatment history, insurance details, and billing records. PHI is created every time you see a doctor, fill a prescription, file an insurance claim, use a patient portal, or receive lab results.

The organizations that handle this information — your physician's office, pharmacy, insurance company, lab, telehealth platform — are all governed by the same core federal law: HIPAA, the Health Insurance Portability and Accountability Act. HIPAA exists specifically to ensure that any entity handling your health data meets strict standards for how it's stored, transmitted, and accessed.

Claimable handles PHI in the course of building your appeal, and we’re fully HIPAA certified. That means we’re held to the same standards as your doctor's office or your insurance company.

What HIPAA compliance actually means

HIPAA gets referenced constantly in healthcare, but most people have never had someone explain what it actually requires in practical terms.

At its core, HIPAA sets rules for how organizations that handle PHI must store, transmit, and control access to that data. It covers things like who within an organization can see your records, how data must be encrypted so it can't be intercepted, what happens in the event of a breach, and under what circumstances your information can be shared with anyone else.

HIPAA isn't a one-time checkbox. It's an ongoing set of requirements that covered organizations must maintain, document, and be able to demonstrate compliance with at any time.

Claimable completed a third-party HIPAA attestation through cybersecurity firm Workstreet in November 2025. That means an independent organization reviewed our data handling practices, security controls, and policies against HIPAA requirements and confirmed that we meet them. This is a higher bar than self-attestation — it means someone from outside the company verified it.

Any partner that handles protected health information on Claimable's behalf is also covered by a Business Associate Agreement (BAA), which legally requires them to maintain the same HIPAA standards.

The security side: What SOC 2 Type II means, in plain English

If HIPAA is the healthcare-specific standard, SOC 2 Type II is the gold standard for security in the technology industry — the way companies prove their systems are trustworthy to the organizations and people who depend on them.

Here's the simplest way to think about it: an independent auditing firm comes in and examines how a company protects data — not just on paper, but in practice, over an extended period of time. They look at security controls, access management, encryption, monitoring, incident response, and operational processes. Then they either certify the company or they don't.

The "Type II" part is important. A Type I audit evaluates whether the right controls exist at a single point in time. A Type II audit evaluates whether those controls actually worked, consistently, over a sustained period. It's the difference between checking that a fire extinguisher is on the wall versus confirming that the fire safety system has been operational and tested for months.

Claimable is SOC 2 Type II certified as of January 2026.

For context, many healthcare providers' offices — the doctor you visit, the urgent care you trust — are required to meet HIPAA standards but do not typically undergo SOC 2 audits. Claimable meets both.

How your data is actually protected

Without getting deep into technical jargon, here's what's happening behind the scenes when you use Claimable.

Your data is encrypted in transit and at rest. "In transit" means while it's being sent between your device and our servers — it's scrambled so that even if someone intercepted it, they couldn't read it. Claimable uses TLS 1.3+, the latest standard for this. "At rest" means while it's stored on our servers, it's encrypted using AES-256, the same standard used by banks and government agencies.

Access to your data within Claimable is restricted by role-based controls. Not everyone on the team can see everything. Access is limited to what's necessary for the function someone performs, and every access requires two-factor authentication.

All activity is logged and monitored. If someone accesses data, there's a record of it. Those activity logs are even accessible to you directly in the Claimable app, so you can see what's happening with your case.

Claimable's infrastructure runs on AWS with multi-layered security including firewalls and intrusion detection. The company conducts annual penetration testing — where security professionals actively try to break in — and maintains an incident response plan with a 72-hour notification commitment.

Other data we collect: Why Claimable asks about your daily life, work, and finances

In addition to medical records and details about your history, Claimable's questionnaire asks about things that might not seem like typical health data: how your condition affects your daily routine, your ability to work, your relationships, and your financial situation.

There's a specific reason for this. A strong appeal doesn't just cite clinical studies and legal standards: it tells the story of what the denial actually means for you as a person. Insurers review appeals, and the human reviewers reading them need to understand the real-world consequences of withholding coverage, not just the clinical justification for the treatment.

When you share that you've had to stop working because your condition makes it physically impossible to do your job, or that routine tasks like cooking and grocery shopping have become painful or impossible, that information becomes part of your appeal's narrative argument. It demonstrates functional impairment and medical necessity in concrete, specific terms that a clinical summary alone can't convey.

This personal context is subject to the same protections as every other piece of data Claimable handles: encrypted, access-controlled, and used exclusively to build your appeal. We collect only the data we need to build a strong appeal, and it goes nowhere else.

What Claimable does NOT do with your data

This is as important as what we do. Claimable does not sell your data. Not to advertisers, not to data brokers, not to anyone. Your health information is not used for marketing or ad targeting. It's fully de-identified and aggregated when we look at things like denial rate trends, and isn’t shared with any third parties.

Claimable's AI uses your case information to build your appeal — and that's it. The system doesn't make medical diagnoses, doesn't recommend treatments, and doesn't share your information outside the scope of your specific case.

You stay in control

Claimable operates on a human-in-the-loop model. The AI generates your appeal based on your case details and the relevant evidence, but you review the final document before anything is submitted. You see exactly what's being sent, to whom, and why. If something doesn't look right, you flag it.

This isn't a system that takes your data and does something opaque with it behind closed doors. You're involved at every decision point, and you can see what's happening with your case through your Claimable account at any time.

Questions you should ask any platform

We'd encourage you to apply the same scrutiny to every service that handles your health data. When evaluating any platform — especially one that uses AI — ask: Are they HIPAA compliant, and has it been independently verified? Do they have SOC 2 Type II certification? What do they do — and not do — with your data? Who has access, and is there an audit trail?

And just as importantly: how does their AI actually work? Is it a wrapper on top of ChatGPT or another general-purpose language model, or have they built a custom system designed specifically for the task? 

A general-purpose AI generates responses from broad internet training data, which means your health information may be processed in ways that aren't purpose-built for privacy or accuracy. A custom-built system like Claimable's uses retrieval-augmented generation from curated, verified sources, so your data is used to build your appeal and nothing else.

Those are the right questions. And we're glad to answer every one of them.

For a deeper look at how Claimable's AI works and why it's uniquely suited to insurance appeals, read our companion post: How Claimable's AI works for patients

If you've been denied coverage for a medication or procedure, start your appeal here.

‍

When you submit a case to Claimable, you get back a fully personalized insurance appeal: built on clinical evidence, your insurer's own policies, and the legal standards that protect your right to coverage. Most cases are resolved in under 10 days, with an 80%+ success rate.

That’s thanks to Claimable’s AI, powering every appeal. But what does it really mean to be AI-powered, and can you trust the tech? Let’s dive into what's actually happening behind the scenes, and why we built it this way.

What a winning appeal requires

To understand why AI is core to what Claimable does, it helps to understand what a strong appeal actually contains. It's not a letter asking your insurer to reconsider. It's a structured argument that weaves together three things simultaneously:

Your story: your specific diagnosis, treatment history, how the denial affects your health and daily life, and what your physician has recommended.

Clinical evidence: published studies, treatment guidelines, and medical precedents that support why this treatment is appropriate for your condition.

Policy and legal analysis: your insurer's own coverage criteria, applicable federal and state laws (like the ACA, ERISA, or state insurance mandates), and the specific procedural requirements your insurer must follow when handling your appeal.

Building that argument well means cross-referencing your specific case details against an enormous body of evidence: millions of clinical studies, thousands of insurer-specific coverage policies, and hundreds of laws and regulations. A physician writing a peer-to-peer or appeal letter draws on their clinical expertise and a handful of familiar references — which is valuable, but represents a fraction of the available evidence that could strengthen the case.

This is the problem Claimable's AI was designed to solve.

How the AI builds your appeal

When you submit your case, you answer a short health questionnaire, add your insurance information, and add your denial letter and other documents. From there, Claimable's AI gets to work.

The system uses retrieval-augmented generation (RAG), which in practical terms means it doesn't generate arguments from general knowledge the way a tool like ChatGPT would. Instead, it searches a curated, verified database of clinical evidence, insurer policies, and legal standards, and pulls the specific sources that are relevant to your case. Every claim in your appeal is grounded in a citable source, not generated from patterns in internet text.

Here's what that looks like for your appeal: the AI identifies the clinical studies and treatment guidelines that support your prescribed treatment for your specific condition. It analyzes your insurer's own coverage policy to find where their denial conflicts with their stated criteria or with established medical standards. It identifies the federal and state laws that apply to your plan type and situation — including mandated timelines, required review processes, and your rights to escalate.

Then it synthesizes all of that into a single, coherent document that tells your story, presents the evidence, and makes the legal case — personalized to your diagnosis, your insurer, and the specific reason they denied your claim.

Built on expert strategy, not just trained on data

There's an important distinction between a general AI model that's been trained on internet text and a system purpose-built through actual domain expertise.

Claimable's AI wasn't built by feeding a model a batch of data and hoping for good results. The appeal strategy for condition and medication on the platform is designed by a person – a clinical and appeals expert who develops the approach the AI will take for each specific scenario. They determine what evidence is most persuasive, which insurer arguments to anticipate and counter, how to structure the case for maximum impact, and what legal and policy standards apply. The AI executes that strategy at scale, but the strategy itself gets hands-on refinement, testing, and vetting by a human before it ever touches a patient's case.

Claimable’s curated evidence database, spanning clinical studies, treatment guidelines, insurer coverage policies, and legal standards, was built through that same process. It's not a static dump of medical literature. It's an actively maintained body of evidence shaped by people who understand what actually wins appeals, organized so the AI can match the right sources to the right case. And it’s constantly being updated to make our appeals as strong as possible. When our platform detects something we don’t expect, like a denial that violates the law, it immediately flags it so the evidence body and appeal strategy can adapt in real time. 

‍

‍

This is also how the platform avoids hallucination (the term for AI-generated content that sounds authoritative but is fabricated). Because Claimable's AI pulls from verified, curated sources rather than generating from general training data, every argument it makes is grounded in a real, citable source. 

And our safeguards go further than sourcing alone. Once the AI generates a first draft, it runs through over a dozen evaluation criteria: cross-checking the appeal against the approved strategy for that condition, verifying that every clinical claim can be substantiated, confirming that legal citations are accurate and applicable to the patient's plan type, and flagging anything that doesn't meet the standard. The appeal that reaches you has been pressure-tested by the same system that built it.

How it improves with every case

Every appeal Claimable processes deepens the system's understanding of what works. Across thousands of real cases, the AI identifies patterns: which types of clinical evidence are most effective for specific denial types, how different insurers respond to different argument structures, which conditions have the highest overturn rates and why, and where particular insurers routinely deny claims that don't hold up on appeal.

This kind of systematic pattern recognition across a high volume of real outcomes is something no individual physician, attorney, or patient advocate can replicate, regardless of how experienced they are. A seasoned appeals specialist might handle a few hundred cases over a career. Claimable's AI draws on the accumulated knowledge from thousands, with each outcome refining what comes next.

The result is an 80%+ success rate, built on evidence that compounds.

Why AI is the right tool for this specific problem

Insurance appeals sit at the intersection of three complex, overlapping domains: clinical medicine, insurance policy, and law. Each one involves a vast and constantly evolving body of information. The task of synthesizing across all three — quickly, accurately, and for a single patient's specific case — is exactly the kind of information processing that AI handles better than manual effort alone.

A typical appeal, done manually, requires 15+ hours of research, writing, and review. Most physicians don't have that time. Most patients don't know where to start. Legal experts can charge thousands for the same work. Claimable compresses that into a process that takes minutes, without sacrificing the depth or rigor that makes an appeal effective.

Meanwhile, over 70% of large U.S. health insurers are already using AI in operations that include claims processing, according to the National Association of Insurance Commissioners. What that means? There’s an AI on the insurance side, trained and ready to find any opportunity to deny your claim. Patients facing those systems deserve access to tools that operate at the same level of sophistication — and that’s exactly what Claimable was built to do.

What the AI doesn't do

Claimable's AI is an administrative and legal tool. It builds the strongest possible argument for the care your doctor has already prescribed. It does not diagnose conditions, recommend treatments, or override your physician's clinical judgment.

You see everything before it's submitted. You approve the final appeal. Your doctor's input still matters, and a supporting letter from your physician paired with a Claimable-generated appeal often creates the strongest possible package.

If you're wondering whether your health data is safe throughout this process, we take that question seriously enough that we wrote a dedicated post about it covering what HIPAA compliance and SOC 2 Type II certification actually mean, how your data is protected, and how to evaluate any platform that handles health information. Read it here.

Claimable's AI-powered platform helps patients overturn insurance denials with an 80%+ success rate across 85+ conditions. If you've been denied coverage for a medication or procedure, start your appeal here.

Insurance Denied Remicade? How to Appeal and Get Covered

Your doctor prescribed Remicade because your condition requires a powerful, proven biologic delivered directly into your bloodstream. Unfortunately, your insurer disagreed. If you’re feeling stuck, don’t be. This guide walks you through exactly how to push back and win.

Remicade (infliximab) has been treating serious autoimmune conditions since its initial FDA approval in 1998. It was the first TNF inhibitor ever approved by the FDA, and it remains a frontline therapy for Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Doctors prescribe it because it works, often when other treatments haven’t.

But insurers have been aggressively steering patients away from brand Remicade and toward biosimilars like Inflectra, Renflexis, and Avsola, and in many cases denying coverage for infliximab entirely until patients clear a gauntlet of prior authorization requirements.

Here’s what the insurance industry doesn’t expect: for you to fight back. Fewer than 1% of denied claims are ever appealed, which saves insurers billions every year. But that statistic reflects how confusing the process is, not how hopeless it is. When patients appeal with solid clinical evidence and the right strategy, overturn rates are dramatically higher. Claimable’s appeals succeed over 80% of the time in established conditions.

Remicade denials are more complicated than most because the drug triggers several types of coverage disputes at once, and the strategy for overturning one type looks nothing like another. This guide covers all of them.

Why Insurance Companies Deny Remicade Coverage

Before you respond to a denial, identify exactly what type you’re dealing with. The evidence you’ll need and the escalation strategy you follow depend entirely on the specific reason your insurer said no. Submitting the wrong type of response wastes time and can exhaust your limited appeal opportunities.

What Makes Remicade Denials Unique

Remicade sits at the intersection of several insurance pressure points that don’t apply to most medications. It’s an IV infusion billed through your medical benefit (not your pharmacy benefit), which opens the door to site-of-care restrictions and benefit-routing errors on top of standard coverage disputes. It has three commercially available biosimilars (Inflectra, Renflexis, and Avsola), and major insurers now require patients to try a biosimilar before they’ll cover brand Remicade. It treats six different autoimmune conditions with completely different step therapy rules. And dose escalation is common, especially for IBD patients, meaning your insurer may approve infliximab at one dose but deny the dose your doctor actually prescribed.

Understanding Your Denial

Denial letters are written in insurer language designed to sound final. They’re not. Here’s how to decode the most common denial types, what they actually mean for your situation, and where to start:

Biosimilar Switch and Formulary Change Denials

This is the denial type generating the most frustration right now. Your insurer isn’t saying you don’t need infliximab. They’re saying they’d rather pay for a different version of it.

Biosimilars are clinically similar to Remicade, and for patients starting infliximab for the first time, a biosimilar may work just fine. But switching a stable patient introduces real variables. Differences in formulation and manufacturing can affect how a biologic behaves in your body, and while clinical studies like the NOR-SWITCH trial have not confirmed increased immunogenicity from switching, the concern remains a recognized consideration in clinical practice. A 2025 study in Gastro Hep Advances found that IBD patients denied biologic therapy had worse clinical outcomes, higher hospitalization rates, and a trend toward more ER visits in the year following denial.

The arguments that win: documented adverse reactions to a biosimilar’s formulation or delivery, a history of disease flares or loss of response during prior medication switches, immunogenicity concerns supported by anti-drug antibody testing, and clinical stability on brand Remicade demonstrated by objective disease activity scores and lab values.

State protections worth checking: several states have enacted non-medical switching laws that may limit your insurer’s ability to force you off a stable biologic for purely cost-driven reasons. If your state has these protections, reference them directly in your appeal. (Related: How to Get a Non-Formulary Drug Covered)

Step Therapy Required

Step therapy is the insurer’s way of making you prove that cheaper options failed before they’ll pay for the one your doctor actually prescribed. For Remicade, that means failing on different drugs depending on your diagnosis:

The critical detail most patients miss: “failure” has a broad medical definition that works in your favor. Side effects, contraindications, and medical reasons a drug is inappropriate all count. Methotrexate, for example, is contraindicated in pregnancy and in patients with chronic liver disease. If a required step therapy drug isn’t appropriate for you, document that in your appeal.

The argument that wins: The 2025 ACG guidelines for Crohn’s disease explicitly recommend against the traditional step-up approach and support early use of advanced therapies, including infliximab, for moderate-to-severe disease. The ACR’s 2021 RA guidelines support biologic therapy for patients who don’t reach their treatment target on conventional DMARDs. Citing these puts the insurer’s demand for additional steps in direct tension with the clinical evidence.

Not Medically Necessary

This denial rarely reflects a thorough clinical judgment. It usually means the PA submission was too thin, and it’s one of the most commonly overturned denial types on appeal. A strong resubmission includes disease severity documented with objective measures (CDAI for Crohn’s, partial Mayo for UC, DAS28 for RA, PASI or BSA for psoriasis), prior failed therapies with specific dates and outcomes, and a clear clinical rationale for why Remicade is the appropriate next treatment.

Dose Escalation Denied

This denial is especially common for IBD patients. Over time, many Remicade patients need a higher dose (5 mg/kg to 10 mg/kg) or shorter intervals (every 6 or 4 weeks instead of 8). Dose optimization is standard clinical practice for TNF inhibitors, but insurers deny these adjustments anyway.

What your appeal needs: clinical evidence of loss of response (rising inflammatory markers, worsening endoscopy findings, increased disease activity scores), your prescriber’s rationale for the specific dose adjustment, trough level and anti-drug antibody testing if available, and references to the 2025 ACG guidelines, which specifically state that biologic dose optimization may be considered for patients with inadequate or loss of response.

Site of Care Restriction

This denial has nothing to do with whether you need Remicade. Insurers increasingly push patients away from hospital outpatient departments toward freestanding infusion centers or home infusion to reduce costs. If the alternative site can safely administer your infusion, transitioning may be the fastest path to continued coverage. But if you have a history of infusion reactions, the alternative facility isn’t equipped for your needs, or the logistics create access barriers, your doctor can submit a site-of-care exception documenting why your current setting is medically necessary.

Wrong Benefit or Administrative Error

Remicade is typically covered under the medical benefit, not the pharmacy benefit, because it’s administered by IV infusion in a clinical setting. Denials sometimes occur simply because the PA was routed to the wrong benefit or the billing codes were outdated.

Before you build a formal appeal, check the basics: Was the PA filed under the medical benefit? Were the correct HCPCS codes used (J1745 for Remicade, Q5103 for Inflectra, Q5104 for Renflexis, Q5121 for Avsola)? Is your infusion facility in-network? If the denial traces back to a routing or coding error, a corrected resubmission resolves it faster than a formal appeal.

How to Appeal a Remicade Denial (Step by Step)

Appeals work far more often than most people think. Insurance companies have spent decades conditioning patients to accept “no” as final. It’s not. When patients appeal with the right evidence and documentation, overturn rates are much higher.

Step 1: Read Your Denial Letter Carefully

Your denial letter is required by law to include the specific reason for denial, your appeal rights, and the deadline to file. Find the deadline first, because it’s the most time-sensitive detail.

Most commercial plans allow 180 days to file an appeal, but there are exceptions. UnitedHealthcare gives just 65 calendar days for many commercial plan types. Medicare Advantage plans follow CMS rules at 60 days. Missing your deadline forfeits your appeal rights regardless of how strong your case is, so move quickly.

Step 2: Know That You Can Appeal Yourself, Not Just Your Doctor

Your provider can and should appeal on the clinical side. But you also have the right to file your own appeal as the patient, and it runs on a separate track with its own protections: guaranteed response timelines, the right to external review by an independent third party, and multiple appeal levels. Use both tracks: your doctor makes the clinical case while you exercise your independent rights.

Step 3: Confirm Your Clinical Documentation Is Complete

Before building your appeal, run through the basics. Is the diagnosis coded correctly with the right ICD-10 codes for your specific condition? Are all required pre-treatment safety screenings (TB test, hepatitis B panel) documented and included? Was the prior authorization submitted under the medical benefit with the correct HCPCS codes?

For patients being switched off brand Remicade: has your doctor documented your clinical stability on the current medication with specific metrics? Disease activity scores, inflammatory markers (CRP, ESR, fecal calprotectin), endoscopy findings, and functional assessments all strengthen an appeal for continuity of care.

Step 4: Get a Letter of Medical Necessity

A letter of medical necessity from your prescribing physician is the single most important document in your appeal package. For Remicade, a strong letter should include your diagnosis with ICD-10 codes and current disease severity scores, your full prior medication history with specific reasons each therapy was stopped, the clinical rationale for Remicade at the prescribed dose and interval, and any safety considerations that affect the choice of infliximab product or infusion setting.

For biosimilar switch appeals, the letter should document your clinical improvement on brand Remicade with measurable outcomes. For dose escalation appeals, include trough levels, anti-drug antibody results, and objective evidence of loss of response at the current dose.

How to ask: be direct with your doctor. “My insurance denied Remicade. Would you be willing to write a letter of medical necessity for my appeal?” If your doctor’s office hasn’t written many of these, offering to share a template can improve the quality of the letter.

Step 5: Build Your Appeal Package

Your complete submission should include a cover letter, the letter of medical necessity, supporting clinical documentation (labs, visit notes, imaging, endoscopy reports, disease severity assessments), and a personal statement describing how the denial has affected your health and daily life. A winning appeal brings together three elements:

Your story. How your condition affects your ability to work, care for your family, and function day to day. If you’ve been stable on Remicade and are being forced to switch, describe what that stability has meant for your quality of life. Reviewers are people. Give them context that data alone can’t convey.

Clinical evidence. Reference authoritative guidelines that support your case: ACG guidelines for Crohn’s disease and ulcerative colitis, ACR guidelines for rheumatoid arthritis, AAD guidelines for psoriasis.

Policy and legal analysis. How your situation meets your plan’s own coverage criteria, relevant state non-medical switching laws if you’re being forced off a stable biologic, and federal protections like the ACA’s appeal and external review requirements. If the insurer’s denial contradicts their published criteria, call it out specifically.

Step 6: Submit and Track

Submit your appeal according to the instructions in your denial letter. Your insurer must respond within 30 days for a standard internal appeal, or within 72 hours for an expedited appeal when your health would be seriously jeopardized by waiting. For Remicade patients with active disease flares, an expedited appeal may be appropriate. Keep records of everything: submission method, date, confirmation numbers, and the name of anyone you speak with.

Step 7: Escalate If Needed

A denied internal appeal isn’t the end. You have the right to request an external review by an independent reviewer who has no relationship with the insurer. External reviewers evaluate the medical justification for your treatment, not whether the insurer wants to pay for it. These reviews are binding on the insurer in most states and regularly overturn denials that make it to this stage.

You can also file a complaint with your state’s Department of Insurance, explore additional legal options for employer-sponsored ERISA plans, or leverage state non-medical switching and step therapy exception laws. Don’t give up after one “no.” The system is designed to make you quit. Persistence is part of the strategy.

An Easier Path: Let Claimable Handle Your Remicade Appeal

If navigating this process feels overwhelming, Claimable can help. You answer a few questions about your Remicade denial and medical history, and we build a fully customized appeal using our database of millions of clinical studies, insurer policies, and legal standards. The appeal includes your personal narrative, clinical evidence matched to your condition and denial type, and a legal analysis targeting your insurer’s reasoning. We submit directly to your insurer and guide you through escalation if needed.

Thousands of biologic appeals have taught us how each major insurer operates and which arguments win for each Remicade denial type.

Appealing with Claimable costs $39.95. No success fees, no hidden costs. When Remicade can cost $4,000 to $7,000 per infusion without coverage, the math is simple.

Start your Remicade appeal →

Appeal Timelines: How Long Does a Remicade Appeal Take?

Typical timelines for each stage of a Remicade insurance appeal.

The single biggest factor in speed is completeness. Appeals that include everything from the start move faster than submissions that trigger back-and-forth requests for additional information. The average Claimable appeal gets a response in just 10 days.

FAQs

Why was my Remicade denied if my doctor prescribed it?

A prescription and an insurance approval are two different things. Most plans require prior authorization for Remicade, and PA criteria often include step therapy requirements, biosimilar preference mandates, site-of-care restrictions, and documentation thresholds that go well beyond a standard prescription order. Your doctor made a clinical decision. The insurer is applying a separate, more restrictive set of rules.

Can I appeal a Remicade denial myself, or does my doctor have to do it?

You can appeal yourself. Patient-initiated appeals are a separate process from provider appeals, and they carry their own legal protections including mandated response timelines and the right to external review. If your doctor’s prior authorization was denied, your patient appeal is an additional opportunity, not a duplicate.

What if my insurer wants me to switch to a Remicade biosimilar?

It depends on your clinical situation. If you’ve been stable on brand Remicade and have documented reasons why switching poses risk (adverse reactions, disease flares during prior switches, immunogenicity concerns), that’s a strong case for a formulary exception. If you haven’t tried a biosimilar and don’t have a clinical contraindication, trying the preferred biosimilar may be the fastest path to continued treatment.

My insurer denied my dose increase for Remicade. What can I do?

Dose escalation and interval shortening are standard clinical practice for Remicade, especially in IBD, and the 2025 ACG guidelines specifically support dose optimization. Your appeal should include objective evidence of loss of response at the current dose, trough levels and antibody testing if available, and your prescriber’s clinical rationale for the adjustment.

What’s the difference between Remicade and Humira?

Both are TNF inhibitors used for many of the same autoimmune conditions, but they differ in important ways. Remicade (infliximab) is given by IV infusion at a medical facility, typically every 6–8 weeks, and billed under the medical benefit. Humira (adalimumab) is a self-administered subcutaneous injection billed under the pharmacy benefit. That billing distinction means they face different denial types and different appeal pathways.

How much does Remicade cost without insurance?

Remicade typically costs between $4,000 and $7,000 per infusion, depending on your weight, dose, and infusion site. Biosimilars cost less. Johnson & Johnson offers the J&J withMe Savings Program for commercially insured patients, which can reduce costs to as little as $5 per infusion.

Is it worth appealing a Remicade denial?

Almost always, yes. Treatment gaps with Remicade carry real clinical consequences: disease flares, loss of response, and the potential development of antibodies that can make the medication less effective if restarted. Research confirms that IBD patients denied biologic therapy have worse outcomes and more hospitalizations. Fewer than 1% of denials are ever challenged, and insurers have built their entire denial infrastructure around that number. Your doctor prescribed Remicade because you need it. The appeal puts that reasoning in front of someone who has to evaluate it on the merits.

Claimable’s physician-led team has helped patients recover over $30 million in care access by fighting insurance denials. We’re SOC 2 Type II certified and HIPAA compliant. Learn more about how Claimable works →